Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma

In this on-demand Webcast of a CCO symposium at ASH 2017, Ranjana Advani, MD, leads an expert panel with Robert W. Chen, MD; Andrew Evens, DO, MSc, FACP; and Pier Luigi Zinzani, MD, PhD, as they review and discuss the latest clinical strategies for managing patients with Hodgkin lymphoma.
Ranjana Advani, MD
Program Director
Robert W. Chen, MD
Andrew M. Evens, DO, MSc, FACP
Pier Luigi Zinzani, MD, PhD
Released: January 24, 2018 Expiration: No longer available for credit

Related Content

Downloadable slideset with highlights from key hematologic cancers as presented at EHA 2022 Congress, from Clinical Care Options (CCO)

Stéphane de Botton, MD Jesús F. San-Miguel, MD, PhD Alessandra Tedeschi, MD Released: June 30, 2022

Experts discuss important new data from ASCO 2022 that may impact treatment for chronic lymphocytic leukemia and mantle cell lymphoma, from Clinical Care Options (CCO)

Brad S. Kahl, MD Anthony Mato, MD, MSCE Released: June 30, 2022

From Clinical Care Options (CCO), download slides reviewing the integration of CAR T-cell therapy into community care

Jesús G. Berdeja, MD Caron A. Jacobson, MD Released: June 30, 2022

Slides from Clinical Care Options (CCO) with key findings on BTK inhibitors in CLL and MCL from the 2022 ASCO, EHA, Pan Pacific, ESMO, and SOHO meetings

Released: June 27, 2022

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by educational grants from
Merck & Co., Inc.
Takeda Oncology
Seattle Genetics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings